Haylex Laboratories Inc.

Biotech Kerrville, TX

About

Issuer

Entity type
Corporation
Jurisdiction
Texas
Sector
Biotech
Headquarters
Kerrville, TX
Street
2317 Trails End
Zip
78028

Offering

Total offering
$1.5M
Amount sold
$50k
First sale
Apr 15, 2026
Min investment
$0
Securities
Equity
Federal exemption
Rule 506(b)
Investors so far
1

How this filing compares

Ranked #30 of 47 Biotech filings in April 2026 by offering amount.

Median Biotech filing in April 2026: $3M. This offering is 0.5× the median.

Other Texas filings this week: 24029 Wildwood, LLC, 97 CROSS A SERIES OF VUCP FUND LLC, Ascend Mineral Springs LLC, BASTROP CEDAR LLC, BKAI OpsCompanion LLC

Leadership

Mark Stephen Malone — Executive Officer (also: Director)

Filing details

Haylex Laboratories Inc. filed a Form D with the SEC on April 21, 2026.

Other newest Biotech companies

Other newest companies in Texas